Evidence map›Paper›PMID 35420651›Full record

ArticleJAMA ophthalmology2022

Association Between Social Determinants of Health and Retinopathy of Prematurity Outcomes.

Reem Karmouta, Marie Altendahl, Tahmineh Romero, Tracy Piersante, Seth Langston, Monica Khitri, Jacqueline Kading, Irena Tsui, Alison Chu

Open access · bronzeAbstract read
In one paragraph

Article in JAMA ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. The characteristics of racial disparity in retinopathy of prematurity outcomes.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A review on retinopathy of prematurity.Medical hypothesis, discovery & innovation ophthalmology journal · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Reem KarmoutaDavid Geffen School of Medicine, Division of Neonatology and Developmental Biology, Department of Pediatrics, University of California, Los Angeles.
Marie AltendahlDavid Geffen School of Medicine, Division of Neonatology and Developmental Biology, Department of Pediatrics, University of California, Los Angeles.
Tahmineh RomeroDavid Geffen School of Medicine, Department of Medicine Statistics Core, University of California, Los Angeles.
Tracy PiersanteDavid Geffen School of Medicine, Division of Neonatology and Developmental Biology, Department of Pediatrics, University of California, Los Angeles.
Seth LangstonDivision of Neonatology, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California.
Monica KhitriDavid Geffen School of Medicine, Department of Ophthalmology, University of California, Los Angeles.
Jacqueline KadingDavid Geffen School of Medicine, Division of Neonatology and Developmental Biology, Department of Pediatrics, University of California, Los Angeles.
Irena TsuiDavid Geffen School of Medicine, Department of Ophthalmology, University of California, Los Angeles.
Alison ChuDavid Geffen School of Medicine, Division of Neonatology and Developmental Biology, Department of Pediatrics, University of California, Los Angeles.
University of California, Los Angeles · USCedars-Sinai Medical Center · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurityR01EY032561 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHU, ALISON · 2021 to 2025
$2.0M
Retinal and choroidal vasculature changes in healthy and high-risk pregnanciesR21EY030295 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TSUI, IRENA · 2020 to 2021
$439k
NCATS NIH HHS UL1 TR001881NEI NIH HHS R01 EY032561NEI NIH HHS R21 EY030295
6 · The paper itself

Abstract

Importance: Previous studies suggest that race or ethnicity may be associated with risk for developing retinopathy of prematurity (ROP). Little is known about how socioeconomic factors mediate the relationship between race or ethnicity and ROP outcomes. Objective: To evaluate how socioeconomic factors, in the context of race and ethnicity, are associated with ROP outcomes. Design, Setting, and Participants: This retrospective cohort study used US Census Bureau income data and electronic medical records from neonatal intensive care units at 4 hospitals, UCLA Mattel Children's Hospital, UCLA Santa Monica Hospital, Cedars-Sinai Medical Center, and Harbor-UCLA Medical Center. Eligible participants included neonates born at a gestational age (GA) of 30 weeks or less, birth weight less than 1500 g, or a GA at birth greater than 30 weeks but with an unstable clinical course. Participants were screened for ROP between January 1, 2010, and December 31, 2020. Exposures: Race and ethnicity data, GA, demographic and clinical information, proxy household income, and health insurance status were collected as risk factors. Main Outcomes and Measures: Diagnosis and severity of ROP were the main study outcomes. Severity was determined according to a classification system developed by the Early Treatment for Retinopathy of Prematurity Cooperative Group. Results: In a crude model, Hispanic neonates were more likely to be diagnosed with ROP (OR, 1.70; 95% CI, 1.20-2.42) and had more severe ROP (OR, 2.24; 95% CI, 1.21-4.15) compared with non-Hispanic White neonates; these associations were no longer found when adjusting for GA and socioeconomic factors (OR, 1.12; 95% CI, 0.68-1.82, and OR, 1.67; 95% CI, 0.80-3.52, for ROP diagnosis and severity, respectively). In a fully adjusted model, lower GA was the primary predictor of ROP incidence (OR, 0.52; 95% CI, 0.48-0.57; P < .001), and higher median household income was associated with higher GA (OR, 0.26; 95% CI, 0.09-0.43; P = .002). Conclusions and Relevance: In this cohort study, GA was the primary driver of disparities in ROP outcomes in a heterogeneous population of neonates in Los Angeles, California. When examined in the context of socioeconomic factors, GA did not differ between racial and ethnic groups. Studies of disparities associated with race and ethnicity should consider these constructs in conjunction with other sociodemographic factors and social determinants of health.

Indexed as

Retinopathy of PrematurityBirth WeightChildCohort StudiesGestational AgeHumansIncidenceInfantInfant, NewbornInfant, Very Low Birth WeightRetrospective StudiesRisk FactorsSocial Determinants of Health

Identifiers

PMID35420651
PMCPMC9011172
OpenAlexW4224104880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.